TAK logo

TAK Operating profit

annual operating profit:

$4.12B+$450.35M(+12.28%)
March 1, 2025

Summary

  • As of today (August 17, 2025), TAK annual operating income is $4.12 billion, with the most recent change of +$450.35 million (+12.28%) on March 1, 2025.
  • During the last 3 years, TAK annual operating profit has fallen by -$1.32 billion (-24.23%).
  • TAK annual operating profit is now -24.23% below its all-time high of $5.43 billion, reached on March 31, 2022.

Performance

TAK Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKincome statement metrics

quarterly operating profit:

$1.28B+$826.71M(+183.92%)
June 1, 2025

Summary

  • As of today (August 17, 2025), TAK quarterly operating income is $1.28 billion, with the most recent change of +$826.71 million (+183.92%) on June 1, 2025.
  • Over the past year, TAK quarterly operating profit has increased by +$209.26 million (+19.61%).
  • TAK quarterly operating profit is now -54.53% below its all-time high of $2.81 billion, reached on December 31, 2008.

Performance

TAK quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKincome statement metrics

TTM operating profit:

$3.42B+$209.26M(+6.52%)
June 1, 2025

Summary

  • As of today (August 17, 2025), TAK TTM operating income is $3.42 billion, with the most recent change of +$209.26 million (+6.52%) on June 1, 2025.
  • Over the past year, TAK TTM operating profit has increased by +$2.15 billion (+169.65%).
  • TAK TTM operating profit is now -33.70% below its all-time high of $5.16 billion, reached on December 31, 2008.

Performance

TAK TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

TAK Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.3%+19.6%+169.7%
3 y3 years-24.2%+9.9%-9.8%
5 y5 years+47.9%-17.9%-9.6%

TAK Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.2%+12.3%-30.7%+408.5%-22.9%+169.7%
5 y5-year-24.2%+47.9%-43.8%+408.5%-32.7%+169.7%
alltimeall time-24.2%+896.7%-54.5%+136.3%-33.7%+348.1%

TAK Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.28B(+183.9%)
$3.42B(+6.5%)
Mar 2025
$4.12B(+12.3%)
$449.50M(-405.4%)
$3.21B(-13.6%)
Dec 2024
-
-$147.17M(-108.0%)
$3.72B(+7.7%)
Sep 2024
-
$1.84B(+72.7%)
$3.45B(+172.1%)
Jun 2024
-
$1.07B(+11.5%)
$1.27B(-11.3%)
Mar 2024
$3.67B(-24.5%)
$956.91M(-331.3%)
$1.43B(-23.9%)
Dec 2023
-
-$413.69M(+21.1%)
$1.88B(-43.6%)
Sep 2023
-
-$341.59M(-127.8%)
$3.34B(-24.8%)
Jun 2023
-
$1.23B(-12.7%)
$4.43B(+1.5%)
Mar 2023
$4.86B(-10.6%)
$1.41B(+35.0%)
$4.37B(+18.7%)
Dec 2022
-
$1.04B(+37.9%)
$3.68B(+0.5%)
Sep 2022
-
$756.01M(-34.9%)
$3.66B(-3.4%)
Jun 2022
-
$1.16B(+61.5%)
$3.79B(-22.6%)
Mar 2022
$5.43B(+28.7%)
$719.44M(-29.8%)
$4.90B(+3.5%)
Dec 2021
-
$1.02B(+15.8%)
$4.74B(-6.8%)
Sep 2021
-
$885.15M(-61.0%)
$5.08B(+9.2%)
Jun 2021
-
$2.27B(+308.8%)
$4.65B(+18.2%)
Mar 2021
$4.22B(+51.6%)
$555.42M(-59.5%)
$3.94B(-12.9%)
Dec 2020
-
$1.37B(+201.1%)
$4.52B(+24.1%)
Sep 2020
-
$455.13M(-70.7%)
$3.64B(-3.7%)
Jun 2020
-
$1.55B(+36.3%)
$3.78B(+43.3%)
Mar 2020
$2.78B(+41.1%)
$1.14B(+131.7%)
$2.64B(+298.7%)
Dec 2019
-
$492.11M(-17.4%)
$661.81M(-43.3%)
Sep 2019
-
$595.43M(+44.9%)
$1.17B(-4.9%)
Jun 2019
-
$410.95M(-149.1%)
$1.23B(-28.8%)
Mar 2019
$1.97B(+11.9%)
-$836.68M(-183.9%)
$1.72B(+31.4%)
Dec 2018
-
$997.55M(+52.1%)
$1.31B(+20.0%)
Sep 2018
-
$655.71M(-27.7%)
$1.09B(+38.0%)
Jun 2018
-
$906.49M(-172.6%)
$791.67M(-51.7%)
Mar 2018
$1.76B(+119.4%)
-$1.25B(-260.3%)
$1.64B(-10.8%)
Dec 2017
-
$778.64M(+119.3%)
$1.84B(+17.3%)
Sep 2017
-
$354.99M(-79.8%)
$1.57B(+20.4%)
Jun 2017
-
$1.75B(-267.2%)
$1.30B(+35.2%)
Mar 2017
$803.16M(-45.1%)
-$1.05B(-306.9%)
$963.07M(-43.2%)
Dec 2016
-
$507.24M(+467.8%)
$1.69B(+2.3%)
Sep 2016
-
$89.33M(-93.7%)
$1.66B(-19.8%)
Jun 2016
-
$1.42B(-545.1%)
$2.07B(+95.2%)
Mar 2016
$1.46B(-17.9%)
-$318.10M(-167.8%)
$1.06B(-176.7%)
Dec 2015
-
$469.49M(-5.8%)
-$1.38B(+22.2%)
Sep 2015
-
$498.36M(+22.0%)
-$1.13B(+1.0%)
Jun 2015
-
$408.54M(-114.8%)
-$1.12B(+23.8%)
Mar 2015
$1.78B
-$2.76B(-482.6%)
-$901.85M(-160.5%)
Dec 2014
-
$720.15M(+41.2%)
$1.49B(+3.8%)
DateAnnualQuarterlyTTM
Sep 2014
-
$509.99M(-18.2%)
$1.43B(-1.6%)
Jun 2014
-
$623.45M(-271.3%)
$1.46B(+3.1%)
Mar 2014
$1.45B(+61.5%)
-$364.01M(-154.7%)
$1.41B(+66.9%)
Dec 2013
-
$665.03M(+24.8%)
$847.19M(+20.9%)
Sep 2013
-
$533.05M(-8.0%)
$700.59M(-6.9%)
Jun 2013
-
$579.46M(-162.3%)
$752.66M(-21.1%)
Mar 2013
$900.28M(-73.2%)
-$930.35M(-279.5%)
$953.73M(-49.4%)
Dec 2012
-
$518.44M(-11.4%)
$1.88B(-8.7%)
Sep 2012
-
$585.12M(-25.0%)
$2.06B(+52.3%)
Jun 2012
-
$780.53M(>+9900.0%)
$1.36B(-58.7%)
Mar 2012
$3.36B(-21.7%)
$101.00K(-100.0%)
$3.28B(-1474.8%)
Dec 2011
-
$697.46M(-667.2%)
-$238.52M(-114.1%)
Sep 2011
-
-$122.97M(-104.5%)
$1.69B(-61.3%)
Jun 2011
-
$2.70B(-176.9%)
$4.37B(+7.9%)
Mar 2011
$4.29B(-5.3%)
-$3.52B(-233.8%)
$4.05B(-8.8%)
Dec 2010
-
$2.63B(+2.9%)
$4.44B(+3.0%)
Sep 2010
-
$2.56B(+7.2%)
$4.31B(+0.6%)
Jun 2010
-
$2.39B(-176.3%)
$4.29B(-2.4%)
Mar 2010
$4.52B(+48.5%)
-$3.13B(-225.1%)
$4.40B(+1.2%)
Dec 2009
-
$2.50B(-1.3%)
$4.34B(-6.6%)
Sep 2009
-
$2.53B(+1.6%)
$4.65B(+4.0%)
Jun 2009
-
$2.49B(-178.4%)
$4.47B(+125.9%)
Mar 2009
$3.05B(-17.7%)
-$3.18B(-213.3%)
$1.98B(-61.6%)
Dec 2008
-
$2.81B(+19.3%)
$5.16B(+119.3%)
Sep 2008
-
$2.35B
$2.35B
Mar 2008
$3.70B(-5.6%)
-
-
Mar 2007
$3.92B(+10.2%)
-
-
Mar 2006
$3.56B(-0.7%)
-
-
Mar 2005
$3.58B(+9.0%)
-
-
Mar 2004
$3.29B(+29.0%)
-
-
Mar 2003
$2.55B(+13.2%)
-
-
Mar 2002
$2.25B(+10.1%)
-
-
Mar 2001
$2.04B(+32.8%)
-
-
Mar 2000
$1.54B(+37.5%)
-
-
Mar 1999
$1.12B(+20.8%)
-
-
Mar 1998
$926.79M(-17.9%)
-
-
Mar 1997
$1.13B(-3.5%)
-
-
Mar 1996
$1.17B(+20.7%)
-
-
Mar 1995
$969.05M(+36.5%)
-
-
Mar 1994
$709.75M(+30.9%)
-
-
Mar 1993
$542.38M(+5.8%)
-
-
Mar 1992
$512.44M(+24.1%)
-
-
Mar 1991
$413.00M
-
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual operating income?
  • What is the all time high annual operating profit for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual operating profit year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly operating income?
  • What is the all time high quarterly operating profit for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly operating profit year-on-year change?
  • What is Takeda Pharmaceutical Company Limited TTM operating income?
  • What is the all time high TTM operating profit for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited TTM operating profit year-on-year change?

What is Takeda Pharmaceutical Company Limited annual operating income?

The current annual operating profit of TAK is $4.12B

What is the all time high annual operating profit for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual operating income is $5.43B

What is Takeda Pharmaceutical Company Limited annual operating profit year-on-year change?

Over the past year, TAK annual operating income has changed by +$450.35M (+12.28%)

What is Takeda Pharmaceutical Company Limited quarterly operating income?

The current quarterly operating profit of TAK is $1.28B

What is the all time high quarterly operating profit for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly operating income is $2.81B

What is Takeda Pharmaceutical Company Limited quarterly operating profit year-on-year change?

Over the past year, TAK quarterly operating income has changed by +$209.26M (+19.61%)

What is Takeda Pharmaceutical Company Limited TTM operating income?

The current TTM operating profit of TAK is $3.42B

What is the all time high TTM operating profit for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high TTM operating income is $5.16B

What is Takeda Pharmaceutical Company Limited TTM operating profit year-on-year change?

Over the past year, TAK TTM operating income has changed by +$2.15B (+169.65%)
On this page